TLSI Q1 2024 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$6M+116.4% YoY

Gross Profit

$5M85.0% margin

Operating Income

-$12M-181.0% margin

Net Income

-$13M-204.7% margin

EPS (Diluted)

$-0.60

QoQ Revenue Growth

+12.9%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$18M

Total Liabilities

$53M

Stockholders' Equity

-$35M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$3M	+116.4%
Gross Profit	$5M	$2M	+136.3%
Operating Income	-$12M	-$10M	-15.5%
Net Income	-$13M	-$8M	-59.9%